Mass spectrometry reveals incorrect drug binding in anti-HIV drugs
Researchers from the University of Oxford (UK) have used mass spectrometry to demonstrate incorrect protein binding in anti-HIV protein inhibitor drugs, which results in unwanted side effects.
Please sign in or register for FREE
Sign in to MedChemNet
Register to MedChemNet – the medicinal chemistry network
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.